Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study.

MLA

Hensley, Kathryn S., et al. “Correction: Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in People Living with HIV in the Netherlands: A Nationwide Prospective Cohort Study.” PLoS Medicine, vol. 20, no. 1, Jan. 2023, p. e1004159. EBSCOhost, https://doi.org/10.1371/journal.pmed.1004159.

APA

Hensley, K. S., Jongkees, M. J., Geers, D., GeurtsvanKessel, C. H., Mueller, Y. M., Dalm, V. A. S. H., Papageorgiou, G., Steggink, H., Gorska, A., Bogers, S., den Hollander, J. G., Bierman, W. F. W., Gelinck, L. B. S., Schippers, E. F., Ammerlaan, H. S. M., van der Valk, M., van Vonderen, M. G. A., Delsing, C. E., Gisolf, E. H., … Rokx, C. (2023). Correction: Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study. PLoS Medicine, 20(1), e1004159. https://doi.org/10.1371/journal.pmed.1004159

Chicago

Hensley, Kathryn S, Marlou J Jongkees, Daryl Geers, Corine H GeurtsvanKessel, Yvonne M Mueller, Virgil A S H Dalm, Grigorios Papageorgiou, et al. 2023. “Correction: Immunogenicity and Reactogenicity of SARS-CoV-2 Vaccines in People Living with HIV in the Netherlands: A Nationwide Prospective Cohort Study.” PLoS Medicine 20 (1): e1004159. doi:10.1371/journal.pmed.1004159.